Monarch Capital Management Inc Merck & Co., Inc. Transaction History

Monarch Capital Management Inc

$365 Million
Q3 2024

A detailed history of Monarch Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Monarch Capital Management Inc holds 116,312 shares of MRK stock, worth $11.4 Million. This represents 3.62% of its overall portfolio holdings.

Number of Shares

116,312

Previous 115,894 0.36%

Holding current value

$11.4 Million

Previous $14.3 Million 7.94%

% of portfolio

3.62%

Previous 4.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$111.15 - $128.97 $46,460 - $53,909	418 Added 0.36%	116,312 $13.2 Million
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $265,055 - $284,667	-2,141 Reduced 1.81%	115,894 $14.3 Million
Q1 2024 Apr 25, 2024	SELL	$113.24 - $131.95 $74,511 - $86,823	-658 Reduced 0.55%	118,035 $15.6 Million
Q4 2023 Jan 17, 2024	SELL	$100.18 - $109.02 $45,581 - $49,604	-455 Reduced 0.38%	118,693 $12.9 Million
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $2,985 - $3,315	-29 Reduced 0.02%	119,148 $12.3 Million
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $140,106 - $152,710	-1,290 Reduced 1.07%	119,177 $13.8 Million
Q1 2023 Apr 25, 2023	SELL	$102.94 - $114.86 $643,375 - $717,875	-6,250 Reduced 4.93%	120,467 $12.8 Million
Q4 2022 Jan 26, 2023	SELL	$87.44 - $112.11 $441,659 - $566,267	-5,051 Reduced 3.83%	126,717 $0
Q3 2022 Oct 20, 2022	SELL	$84.53 - $94.96 $225,103 - $252,878	-2,663 Reduced 1.98%	131,768 $11.4 Million
Q2 2022 Jul 20, 2022	SELL	$83.49 - $94.64 $441,328 - $500,267	-5,286 Reduced 3.78%	134,431 $12.3 Million
Q1 2022 Apr 20, 2022	BUY	$73.51 - $82.4 $65,129 - $73,006	886 Added 0.64%	139,717 $11.5 Million
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $69,677 - $87,280	-964 Reduced 0.69%	138,831 $10.6 Million
Q3 2021 Nov 04, 2021	BUY	$71.68 - $78.83 $73,758 - $81,116	1,029 Added 0.74%	139,795 $10.5 Million
Q2 2021 Jul 22, 2021	BUY	$70.31 - $77.77 $1,476 - $1,633	21 Added 0.02%	138,766 $10.8 Million
Q1 2021 Apr 27, 2021	SELL	$68.86 - $81.11 $58,668 - $69,105	-852 Reduced 0.61%	138,745 $10.7 Million
Q4 2020 Jan 26, 2021	SELL	$71.77 - $79.65 $58,779 - $65,233	-819 Reduced 0.58%	139,597 $11.4 Million
Q3 2020 Oct 22, 2020	SELL	$73.18 - $82.95 $17,709 - $20,073	-242 Reduced 0.17%	140,416 $11.6 Million
Q2 2020 Jul 23, 2020	BUY	$70.42 - $80.13 $61,828 - $70,354	878 Added 0.63%	140,658 $10.9 Million
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $112,654 - $156,143	1,778 Added 1.29%	139,780 $10.8 Million
Q4 2019 Jan 28, 2020	SELL	$77.58 - $87.54 $120,792 - $136,299	-1,557 Reduced 1.12%	138,002 $12.6 Million
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $214,241 - $233,530	-2,816 Reduced 1.98%	139,559 $11.7 Million
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $60,271 - $70,412	-863 Reduced 0.6%	142,375 $11.9 Million
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $97,412 - $111,104	-1,400 Reduced 0.97%	143,238 $11.9 Million
Q4 2018 Jan 23, 2019	SELL	$65.24 - $75.71 $62,956 - $73,060	-965 Reduced 0.66%	144,638 $11.1 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $311,756 - $366,607	-5,404 Reduced 3.58%	145,603 $10.3 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $236,816 - $278,235	-4,659 Reduced 2.99%	151,007 $9.17 Million
Q1 2018 Apr 18, 2018	BUY	$50.96 - $59.23 $253,373 - $294,491	4,972 Added 3.3%	155,666 $8.48 Million
Q4 2017 Jan 31, 2018	SELL	$51.62 - $61.64 $170,862 - $204,028	-3,310 Reduced 2.15%	150,694 $8.48 Million
Q3 2017 Oct 18, 2017	BUY	$58.67 - $63.13 $9.04 Million - $9.72 Million	154,004	154,004 $9.86 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.

Account

Monarch Capital Management Inc Merck & Co., Inc. Transaction History